CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Sales | 95,428,000 | 91,234,000 | 88,437,000 | 93,813,000 | 89,764,000 |
Cost of Goods | 52,948,000 | 49,998,000 | 48,073,000 | 57,419,000 | 54,688,000 |
Gross Profit | 42,480,000 | 41,236,000 | 40,364,000 | 36,394,000 | 35,076,000 |
Operating Expenses | 41,648,000 | 38,191,000 | 38,093,000 | 33,021,000 | 31,386,000 |
Operating Income | 832,000 | 3,045,000 | 2,271,000 | 3,373,000 | 3,690,000 |
Interest Expense | 752,000 | 732,000 | 716,000 | 690,000 | 693,000 |
Other Income | 25,000 | 24,000 | 25,000 | 22,000 | 22,000 |
Pre-tax Income | 105,000 | 2,337,000 | 1,580,000 | 2,705,000 | 3,019,000 |
Income Tax | 34,000 | 569,000 | 456,000 | 658,000 | 754,000 |
Net Income Continuous | 71,000 | 1,768,000 | 1,124,000 | 2,047,000 | 2,265,000 |
Minority Interests | -16,000 | -2,000 | 11,000 | 1,000 | 4,000 |
Net Income | $87,000 | $1,770,000 | $1,113,000 | $2,046,000 | $2,261,000 |
EPS Basic Total Ops | 0.07 | 1.41 | 0.88 | 1.59 | 1.76 |
EPS Basic Continuous Ops | 0.06 | 1.41 | 0.89 | 1.59 | 1.76 |
EPS Diluted Total Ops | 0.07 | 1.41 | 0.88 | 1.59 | 1.75 |
EPS Diluted Continuous Ops | 0.06 | 1.40 | 0.89 | 1.58 | 1.76 |
EPS Diluted Before Non-Recurring Items | 1.09 | 1.83 | 1.31 | 2.12 | 2.21 |
EBITDA(a) | $1,993,000 | $4,196,000 | $3,409,000 | $4,507,000 | $4,817,000 |